scorecardresearch
Tuesday, November 5, 2024
TopicGlaxoSmithKline

Topic: GlaxoSmithKline

Blob that created history — tracking six-decade quest for respiratory syncytial virus vaccine

GlaxoSmithKline’s vaccine for respiratory syncytial virus was approved by The Medicines and Healthcare products Regulatory Agency in Britain on Monday.

WHO approves Glaxo and Eli Lilly drugs to treat Covid amid Omicron surge

Eli Lilly’s rheumatoid arthritis drug and GlaxoSmithKline's monoclonal antibody won the WHO nod.

GlaxoSmithKline, CureVac team up to develop vaccines to tackle Covid variants

The immunisations may be used to protect people who haven’t been inoculated or as booster shots if immunity from other vaccines wanes.

Sanofi and Glaxo start human trials for Covid-19 vaccine

The drugmakers, who have 11 trial sites across the US, aim to have results by December, allowing for the final phase of trials to begin.

Sanofi expects to get approval for its coronavirus vaccine in first half of 2021

Paris-based pharma giant Sanofi’s program with Britain's Glaxo is one of dozens sprinting to deliver a vaccine to help end the pandemic.

Unilever needs luck to gain energy from Horlicks deal in India

Horlicks is facing a challenge, even in India. The drink is losing its star status as the ‘healthy’ morning and after-school drink.

Glaxo to consider selling its stake in Indian consumer unit worth $3.1 bn

Revenue at GlaxoSmithKline's consumer unit in India has decreased in the last two years.  Its bestselling malted milk drink brand Horlicks will also be sold.

On Camera

Trudeau is nursing snakes in his own backyard. Misguided Sikhs in Canada are losing the plot

By turning a blind eye to the snakes in his own backyard, Trudeau is setting the stage for a disaster of epic proportions for his country, his people, and the world at large.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

India carries out 1st patrol in Depsang since disengagement with China, to take things ‘slow’

While there are patrolling points (PP) 10, 11, 12, 12A and 13 in the Depsang Plains, the patrol in the region Monday was carried out to only one point as decided by India and China.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.